Orthofix Medical Inc. Finance Lease, Liability, Undiscounted Excess Amount
Orthofix Medical Inc. (OFIX) had Finance Lease, Liability, Undiscounted Excess Amount of $6.41 million as of 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-24
- 2025-12-31: Finance Lease, Liability, Undiscounted Excess Amount $6.41M.
- 2024-12-31: Finance Lease, Liability, Undiscounted Excess Amount $7.20M.
- 2023-12-31: Finance Lease, Liability, Undiscounted Excess Amount $8.02M.
- 2022-12-31: Finance Lease, Liability, Undiscounted Excess Amount $8.87M.
| Period end | Finance Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $6.41M 10-K · filed 2026-02-24 |
| 2024-12-31 | $7.20M 10-K · filed 2025-02-25 |
| 2023-12-31 | $8.02M 10-K · filed 2024-03-05 |
| 2022-12-31 | $8.87M 10-K · filed 2023-03-06 |
| 2021-12-31 | $9.76M 10-K · filed 2022-02-25 |
| 2020-12-31 | $10.69M 10-K · filed 2021-02-26 |
| 2019-12-31 | $11.58M 10-K · filed 2020-02-24 |
| 2019-09-30 | $11.81M 10-Q · filed 2019-10-28 |
| 2019-06-30 | $12.04M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $12.27M 10-Q · filed 2019-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |